Published in Am J Hypertens on January 01, 1995
Essential hypertension: polymorphonuclear leukocyte membrane fluidity at baseline and after chemotactic activation. Am J Hypertens (1999) 1.40
Patient recall of medication details in the outpatient clinic. Audit and assessment of the value of printed instructions requesting patients to bring medications to clinic. Postgrad Med J (2002) 0.75
Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Diabet Med (2010) 2.13
Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol (2000) 1.74
Relationships between metabolic syndrome and left ventricular mass in hypertensive patients: does sex matter? J Hum Hypertens (2008) 1.44
Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease. J Hum Hypertens (2010) 1.44
Essential hypertension: polymorphonuclear leukocyte membrane fluidity at baseline and after chemotactic activation. Am J Hypertens (1999) 1.40
Pulsatile and steady 24-h blood pressure components as determinants of left ventricular mass in young and middle-aged essential hypertensives. J Hum Hypertens (2003) 1.40
Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today (1997) 1.37
Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci U S A (1995) 1.35
alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am J Physiol (1999) 1.21
Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med (2005) 1.15
Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol (1998) 1.08
Acute effects of coffee on endothelial function in healthy subjects. Eur J Clin Nutr (2010) 1.03
Toward noninvasive 3-D imaging of the time course of cortical activity: investigation of the depth of the event-related optical signal. Neuroimage (2000) 1.03
alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J Leukoc Biol (1996) 1.03
Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actions. J Neurosci (1994) 1.02
Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease. Clin Nephrol (2007) 1.01
The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation (1994) 1.01
Thyroidectomy with ultrasonic dissector: a multicentric experience. G Chir (2010) 0.99
Low relative resting metabolic rate and body weight gain in adult Caucasian Italians. Int J Obes (Lond) (2005) 0.99
Effects of exercise on inflammation markers in type 2 diabetic subjects. Acta Diabetol (2011) 0.98
Antiinflammatory effects of the neuropeptide alpha-MSH in acute, chronic, and systemic inflammation. Ann N Y Acad Sci (1994) 0.98
Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone. J Neuroimmunol (1999) 0.98
alpha-MSH modulates experimental inflammatory bowel disease. Peptides (1997) 0.98
Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects. Eur J Clin Nutr (2009) 0.96
Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography. Abdom Imaging (2004) 0.95
Thorndike's Legacy: Learning, Selection, And The Law Of Effect. J Exp Anal Behav (1999) 0.95
Systemically administered alpha-melanocyte-stimulating peptides inhibit NF-kappaB activation in experimental brain inflammation. Brain Res (1999) 0.93
Pavlov And Skinner: Two Lives In Science (An Introduction To B. F. Skinner's "Some Responses To The Stimulus 'Pavlov' "). J Exp Anal Behav (1999) 0.92
Mechanisms of antiinflammatory action of alpha-MSH peptides. In vivo and in vitro evidence. Ann N Y Acad Sci (1999) 0.91
Within-patient variability of hormone and cytokine concentrations in heart failure. Pharmacol Res (1998) 0.90
Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med (2004) 0.90
Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte- stimulating hormone. Neuroimmunomodulation (1999) 0.89
Central neurogenic antiinflammatory action of alpha-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology (1994) 0.89
MR-imaging of post-traumatic olivary hypertrophy. Funct Neurol (1995) 0.89
The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with beta-amyloid protein. Neurosci Lett (2000) 0.88
Reproducibility of bowel ultrasonography in the evaluation of Crohn's disease. Dig Liver Dis (2008) 0.88
alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation. Exp Neurol (1999) 0.87
Diagnostic utility of thyroglobulin measurement in the fine needle aspirates from cervical lymph nodes: a case report. G Chir (2012) 0.87
Alpha-MSH peptides inhibit acute inflammation induced in mice by rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine (1992) 0.87
Plasma cortisol response to ACTH does not accurately indicate the state of hypothalamic-pituitary-adrenal axis. J Endocrinol Invest (1983) 0.87
Insulin, renin-aldosterone system and blood pressure in obese people. Int J Obes Relat Metab Disord (2001) 0.87
Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage. Br J Pharmacol (2007) 0.87
The urokinase plasminogen activating system in thyroid cancer: clinical implications. G Chir (2012) 0.86
Granulocyte integrins before and after activation in acute ischaemic stroke. J Neurol Sci (2001) 0.86
Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in human hypertension. Am J Hypertens (1998) 0.86
Role of genetic polymorphisms in myocardial infarction at young age. Clin Hemorheol Microcirc (2010) 0.86
Thyroid tissue remnants after "total thyroidectomy". G Chir (2009) 0.85
Central administration of the peptide alpha-MSH inhibits inflammation in the skin. Peptides (1992) 0.85
Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens (1996) 0.85
Mechanisms of antiinflammatory action of the neuroimmunomodulatory peptide alpha-MSH. Ann N Y Acad Sci (1998) 0.84
Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma. Biochem Biophys Res Commun (1999) 0.84
Prolonged presence of isoxsuprine in equine serum after oral administration. Xenobiotica (1994) 0.84
Functionally reversible hepatic arteriovenous fistulas during pregnancy in patients with hereditary hemorrhagic telangiectasia. South Med J (1988) 0.84
Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension. Clin Ther (1987) 0.84
Gastric involvement in AIDS associated cryptosporidiosis. Gut (1998) 0.84
Effects of hypocaloric very-low-carbohydrate diet vs. Mediterranean diet on endothelial function in obese women*. Eur J Clin Invest (2009) 0.83
Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function. J Hum Hypertens (2007) 0.83
Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway? Cephalalgia (2002) 0.83
Gonadotropin releasing hormone elicits abnormal hormone responses in schizophrenia. Psychoneuroendocrinology (1985) 0.83
Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage. Minerva Cardioangiol (2006) 0.83
Elective endovascular vs. open repair for abdominal aortic aneurysm in patients aged 80 years and older: systematic review and meta-analysis. Eur J Vasc Endovasc Surg (2011) 0.83
US evaluation of patients affected by IBD: how to do it, methods and findings. Eur J Radiol (2009) 0.82
Is pattern III as evidenced by US color-Doppler useful in predicting thyroid nodule malignancy? Large-scale retrospective analysis. Clin Ter (2010) 0.82
Abdominal pain and bowel dysfunction: diagnostic role of intestinal ultrasound. Eur J Gastroenterol Hepatol (2001) 0.82
Essential hypertension. The behaviour of the haemorheological determinants and their trends during beta-blocker treatment. Jpn Heart J (1983) 0.82
Diabetes mellitus: oxidative stress and wine. Curr Med Res Opin (2003) 0.82
Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells. Br J Cancer (2012) 0.82
Impairment of plasma nitric oxide availability in senescent healthy individuals: apparent involvement of extracellular superoxide dismutase activity. Clin Hemorheol Microcirc (2006) 0.82
Haemorheological profile in metabolic Syndrome. Clin Hemorheol Microcirc (2002) 0.82
Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes. J Leukoc Biol (2000) 0.82
A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation (1997) 0.81
Angiomegaly and arterial aneurysms. G Chir (2010) 0.81
Inhibition of IL-1 beta-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide alpha-MSH. Brain Res Bull (1993) 0.81
Red cell peroxide metabolism in diabetes mellitus. Horm Metab Res (1987) 0.81
In vivo relationship between insulin and endothelin role of insulin-resistance. J Hum Hypertens (1997) 0.80
Gender and the systemic hypertension-snoring association: a questionnaire-based case-control study. Blood Press (1998) 0.80
Plasma concentrations of alpha-melanocyte-stimulating hormone are elevated in patients on chronic haemodialysis. Nephrol Dial Transplant (2000) 0.80
Neuropeptide alpha-MSH antagonizes IL-6- and TNF-induced fever. Peptides (1991) 0.80
ACTH and cortisol secretion in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry (1991) 0.80
Insulin resistance and endogenous digoxin-like factor in obese hypertensive patients with glucose intolerance. Acta Diabetol (1992) 0.80
Haemorheological pattern in young adults with acute myocardial infarction. Clin Hemorheol Microcirc (2003) 0.80
Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. Am Heart J (1995) 0.80
Oxidative stress and inflammation in long-term renal transplanted hypertensives. Clin Nephrol (2006) 0.79
Radical axillary dissection in sentinel lymph node biopsy era: it's still a considerable technique in breast cancer management? G Chir (2010) 0.79
Current uses of diagnostic high-frequency US in dermatology. Eur J Radiol (1998) 0.79
Effects of the Aurora kinases pan-inhibitor SNS-314 mesylate on anaplastic thyroid cancer derived cell lines. Clin Ter (2012) 0.79